Elrevolan^®

Elrevolan^® (eltrombopag) belongs to a group of medicines called thrombopoietin-receptor agonists. It is used to help increase the number of platelets in your blood. Platelets are blood cells that help to reduce or prevent bleeding.

Therapeutic indications:

1. Elrevolan^® is used to treat primary immune thrombocytopenia (ITP) in adults and children aged 1 year and above who have already taken other medicines (corticosteroids or immunoglobulins), which did not have a sufficient effect. ITP is caused by a low blood platelet count (thrombocytopenia). People with ITP have an increased risk of bleeding. Symptoms patients with ITP may notice include petechiae (pinpoint-sized flat round red spots under the skin), bruising, nosebleeds, bleeding gums and not being able to control bleeding if they are cut or injured.
2. Elrevolan^® can also be used to treat low platelet count (thrombocytopenia) in adults with hepatitis C virus (HCV) infections, if they have had problems with side effects while on interferon treatment. Many people with hepatitis C have low platelet counts, not only as a result of the disease, but also due to some of the antiviral medicines that are used to treat it. Taking Elrevolan^® may make it easier for you to complete a full course of antiviral medicine (peginterferon and ribavirin).